Global Immunohematology and Infectious Disease NAT Screening: Market Shares by Country, Emerging Technologies, Strategic Profiles of Leading Suppliers

Global Immunohematology and Infectious Disease NAT Screening: Market Shares by Country, Emerging Technologies, Strategic Profiles of Leading Suppliers

  • July 2019 •
  • 154 pages •
  • Report ID: 5791762 •
  • Format: PDF
Global Immunohematology and Infectious Disease NAT Screening: Market Shares by Country, Emerging Technologies, Strategic Profiles of Leading Suppliers

This 154-page report provides assessments of such technologies as molecular diagnostics, monoclonal and polyclonal antibodies, immunoassays, microtitration plates, IT, lasers, synthetic red cell substitutes, genetically engineered blood components, blood preservation, autologous blood transfusion/freezing and their potential applications for blood banking. 
                                                                              
The report also presents strategic assessments of current and emerging suppliers of blood banking products, including their sales, product portfolios, marketing tactics, technological know-how, new products in RandD, collaborative arrangements, and business strategies.

Contains 154 pages


Companies Profiled
Competitive Assessments

- Abbott
- Beckman Coulter/Danaher
- Becton Dickinson
- Biokit
- bioMerieux
- Bio-Rad
- Diagast
- DiaSorin
- Fujirebio
- Grifols
- Hologic
- Immucor
- LabCorp
- Ortho-Clinical Diagnostics
- Proteome Sciences
- Quest Diagnostics
- Quidel
- Roche
- Siemens Healthineers
- Tecan
- Thermo Fisher